Download Publikationen aller KHFI Mitglieder 2011-2015

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Publikationen aller KHFI Mitglieder 2011-2015
(Stand 01.06.2015)
2015
(38)
1.
Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat
Rev Cardiol. 2015 Apr 7: In press.
2.
Baker JO, Tyther R, Liebetrau C, Clark J, Howarth R, Patterson T, Möllmann H, Nef H, Sicard P,
Kailey B, Devaraj R, Redwood SR, Kunst G, Weber E, Marber MS. Cardiac myosin-binding
protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol. 2015 May;
110(3): 478.
3.
Bandorski D, Bogossian H, Braun O, Frommeyer G, Zarse M, Holtgen R, Liebetrau C. Patients
with atrial fibrillation complicated by coronary artery disease : Is a single value of sensitive
cardiac troponin I on admission enough? Herzschrittmacherther Elektrophysiol. 2015 Mar; 26(1):
39-44.
4.
Bauer T, Hochadel M, Brachmann J, Schächinger V, Boekstegers P, Zrenner B, Zahn R, Zeymer
U. Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST
elevation myocardial infarction without cardiogenic shock: Results from the ALKK PCI registry.
Catheter Cardiovasc Interv. 2015 May 6: In press.
5.
Bestehorn K, Bauer T, Fleck E, Bestehorn M, Pauletzki J, Hamm C. Coronary procedures in
German hospitals: a detailed analysis for specific patient clusters. Clin Res Cardiol. 2015 Jan 28:
In press.
6.
Blumenstein J, Kim WK, Liebetrau C, Gaede L, Kempfert J, Walther T, Hamm C, Möllmann H.
Challenges of coronary angiography and intervention in patients previously treated by TAVI.
Clin Res Cardiol. 2015 Feb 27: In press.
7.
Boeder NF, Schmitt J, Rixe J, Nef HM. Trapped cardioverter-defibrillator lead after
interventional closure of an iatrogenic atrial septal defect after catheter-based mitral valve repair
with the MitraClip(R) system. Int J Cardiol. 2015 Feb 25; 184C: 412-413.
8.
Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C,
Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A,
Naganuma T, Munzel T, Tamburino C. Percutaneous coronary intervention with everolimuseluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes
from the European multicentre GHOST-EU registry. EuroIntervention. 2015 Feb; 10(10): 114453.
9.
Dörr O, Ewen S, Liebetrau C, Möllmann H, Gaede L, Linz D, Hohl M, Troidl C, Bauer T, Böhm
M, Hamm C, Mahfoud F, Nef H. Neuropeptide Y as an indicator of successful alterations in
sympathetic nervous activity after renal sympathetic denervation. Clin Res Cardiol. 2015 May 26:
In press.
10.
Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Haidner V, Wiebe J, Voss S, Bauer T,
Hamm C, Nef H. Brain-Derived Neurotrophic Factor as a Marker for Immediate Assessment of
the Success of Renal Sympathetic Denervation. J Am Coll Cardiol. 2015 Mar 24; 65(11): 1151-3.
11.
Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Morczeck K, Wiebe J, Hoffmann J, Voss
S, Bauer T, Hamm C, Nef H. Influence of Renal Sympathetic Denervation on Cardiac
Extracellular Matrix Turnover and Cardiac Fibrosis. Am J Hypertens. 2015 Mar 11: In press.
12.
Dörr O, Liebetrau C, Möllmann H, Mahfoud F, Ewen S, Gaede L, Troidl C, Hoffmann J, Busch
N, Laux G, Wiebe J, Bauer T, Hamm C, Nef H. Beneficial effects of renal sympathetic
denervation on cardiovascular inflammation and remodeling in essential hypertension. Clin Res
Cardiol. 2015 Oct 18; 104(2): 175-184.
13.
Dörr O, Liebetrau C, Wiebe J, Hecker F, Rixe J, Möllmann H, Hamm C, Nef H. Bioresorbable
scaffolds for the treatment of in-stent restenosis. Heart Vessels. 2015 Jan 4; 30(2): 265-269.
14.
Hoffmann J, Shmeleva EV, Boag SE, Fiser K, Bagnall A, Murali S, Dimmick I, Pircher H,
Martin-Ruiz C, Egred M, Keavney B, von Zglinicki T, Das R, Todryk S, Spyridopoulos I.
Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated
immunosenescence in CMV-seropositive patients. Circ Res. 2015 Jan 2; 116(1): 87-98.
15.
Kempfert J, Meyer A, Kim WK, Van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther
T. Comparison of two valve systems for transapical aortic valve implantation: a propensity scorematched analysis. Eur J Cardiothorac Surg. 2015 Feb 10: In press.
16.
Kim WK, Kempfert J, Walther T, Möllmann H. Transfemoral valve-in-valve implantation of a St.
Jude Medical Portico in a failing trifecta bioprosthesis: a case report. Clin Res Cardiol. 2015 Apr;
104(4): 363-5.
17.
Kim WK, Rolf A, Möllmann H. Reply: Could Late Enhancement and Need for Permanent
Pacemaker Implantation in Patients Undergoing TAVR Be Explained by Undiagnosed
Transthyretin Cardiac Amyloidosis? J Am Coll Cardiol. 2015 Jan 27; 65(3): 312-3.
18.
Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Möllmann H, Naber CK, Schunkert H,
Thiele H, Hamm C. Qualitätskriterien zur Durchführung der transvaskulären
Aortenklappenimplantation (TAVI). Der Kardiologe. 2015 2014/12/06; 9(1): 11-26.
19.
Liebetrau C, Hoffmann J, Dörr O, Gaede L, Blumenstein J, Biermann H, Pyttel L, Thiele P,
Troidl C, Berkowitsch A, Rolf A, Voss S, Hamm CW, Nef H, Möllmann H. Release kinetics of
inflammatory biomarkers in a clinical model of acute myocardial infarction. Circ Res. 2015 Feb
27; 116(5): 867-75.
20.
Liebetrau C, Hoffmann J, Nef H, Möllmann H. Response to Letter Regarding Article, "Revisiting
the Role of sCD40L as an Inflammatory Biomarker in a Clinical Model of Acute Myocardial
Infarction". Circ Res. 2015 Feb 13; 116(4): e27.
21.
Möllmann H, Kim WK, Kempfert J, Walther T, Hamm C. Complications of transcatheter aortic
valve implantation (TAVI): how to avoid and treat them. Heart. 2015 Feb 6: In press.
22.
Opolski MP, Achenbach S, Schuhback A, Rolf A, Möllmann H, Nef H, Rixe J, Renker M,
Witkowski A, Kepka C, Walther C, Schlundt C, Debski A, Jakubczyk M, Hamm CW. Coronary
Computed Tomographic Prediction Rule for Time-Efficient Guidewire Crossing Through
Chronic Total Occlusion: Insights From the CT-RECTOR Multicenter Registry (Computed
Tomography Registry of Chronic Total Occlusion Revascularization). JACC Cardiovasc Interv.
2015 Feb; 8(2): 257-67.
23.
Opolski MP, Kim W, Liebetrau C, Walther C, Blumenstein J, Gaede L, Kempfert J, Van Linden
A, Walther T, Hamm CW, Möllmann H. Diagnostic accuracy of computed tomography
angiography for the detection of coronary artery disease in patients referred for transcatheter
aortic valve implantation. Clin Res Cardiol. 2015 Jan 6: In press.
24.
Parahuleva MS, Burgazli M, Langanke E, Dorr O, Parviz B, Mericliler M, Parahuleva N,
Holschermann H, Erdogan A. Monocyte CD40 expression in young healthy female smokers
and/or oral contraceptives users without additional risk factors for atherosclerosis. Thromb Res.
2015 Feb; 135(2): 260-6.
25.
Pelliccia F, Parodi G, Greco C, Antoniucci D, Brenner R, Bossone E, Cacciotti L, Capucci A,
Citro R, Delmas C, Guerra F, Ionescu CN, Lairez O, Larrauri-Reyes M, Lee PH, Mansencal N,
Marazzi G, Mihos CG, Morel O, Nef HM, Nunez Gil IJ, Passaseo I, Pineda AM, Rosano G,
Santana O, Schneck F, Song BG, Song JK, Teh AW, Ungprasert P, Valbusa A, Wahl A, Yoshida
T, Gaudio C, Kaski JC. Comorbidities Frequency in Takotsubo Syndrome: An International
Collaborative Systematic Review Including 1,109 Patients. Am J Med. 2015 Feb 3: In press.
26.
Rohrbach S, Troidl C, Hamm C, Schulz R. Ischemia and reperfusion related myocardial
inflammation: A network of cells and mediators targeting the cardiomyocyte. IUBMB Life. 2015
Apr 8: In press.
27.
Rolf A, Rixe J, Kim WK, Guth S, Korlings N, Möllmann H, Nef HM, Liebetrau C, Krombach G,
Kramm T, Mayer E, Hamm CW. Pulmonary vascular remodeling before and after pulmonary
endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac
magnetic resonance study. Int J Cardiovasc Imaging. 2015 Mar; 31(3): 613-9.
28.
Schächinger V, Nef H, Achenbach S, Butter C, Deisenhofer I, Eckardt L, Eggebrecht H, Kuon E,
Levenson B, Linke A, Madlener K, Mudra H, Naber CK, Rieber J, Rittger H, Walther T, Zeus T,
Kelm M. Arbeitsanweisung in Herzkatheterlabor und Hybridoperationssaal. Der Kardiologe.
2015 2015(1): 29-34.
29.
Schreckenberg R, Dyukova E, Sitdikova G, Abdallah Y, Schlüter KD. Mechanisms by which
calcium receptor stimulation modifies electromechanical coupling in isolated ventricular
cardiomyocytes. Pflugers Arch. 2015 Feb; 467(2): 379-88.
30.
Schuhbaeck A, Weingartner C, Arnold M, Schmid J, Pflederer T, Marwan M, Rixe J, Nef H,
Schneider C, Lell M, Uder M, Ensminger S, Feyrer R, Weyand M, Achenbach S. Aortic annulus
eccentricity before and after transcatheter aortic valve implantation: Comparison of balloonexpandable and self-expanding prostheses. Eur J Radiol. 2015 Apr 18: In press.
31.
Tamburino C, Latib A, van Geuns RJ, Sabate M, Mehilli J, Gori T, Achenbach S, Pan Alvarez M,
Nef H, Lesiak M, Di Mario C, Colombo A, Naber CK, Caramanno G, Capranzano P, Brugaletta
S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras SA, Rzeszutko L, Depukat R, Diletti R,
Boone E, Capodanno D, Dudek D. Contemporary practice and technical aspects in coronary
intervention with bioresorbable scaffolds: a European perspective. EuroIntervention. 2015 Jan 21;
10(10).
32.
Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen
K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B,
Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H,
Schneider S, Ebelt H, Werdan K, Zeymer U. Intraaortic balloon counterpulsation in acute
myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic
Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2015 Apr; 169(4):
e7-8.
33.
Van Aelst LN, Voss S, Carai P, Van Leeuwen R, Vanhoutte D, Sanders-van Wijk S, Eurlings L,
Swinnen M, Verheyen FK, Verbeken E, Nef H, Troidl C, Cook SA, Brunner-La Rocca HP,
Möllmann H, Papageorgiou AP, Heymans S. Osteoglycin prevents cardiac dilatation and
dysfunction after myocardial infarction through infarct collagen strengthening. Circ Res. 2015
Jan 30; 116(3): 425-36.
34.
Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner N, Mudra H, Beckmann
A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Möllmann H. Peri-operative results and
complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve
RegistrY (GARY). J Am Coll Cardiol. 2015 Mar 10: In press.
35.
Wiebe J, Bauer T, Dörr O, Möllmann H, Hamm CW, Nef HM. Implantation of a novolimuseluting bioresorbable scaffold with a strut thickness of 100 microm showing evidence of selfcorrection. EuroIntervention. 2015 Feb 6: In press.
36.
Wiebe J, Hamm C, Nef H. A true bifurcational stenosis treated with a bioresorbable vascular
scaffold and a drug-eluting metallic stent: Degradable meets durable. Catheter Cardiovasc Interv.
2015 Jan 10: In press.
37.
Wiebe J, Liebetrau C, Dörr O, Most A, Weipert K, Rixe J, Bauer T, Möllmann H, Elsässer A,
Hamm CW, Nef HM. Feasibility of everolimus-eluting bioresorbable vascular scaffolds in
patients with chronic total occlusion. Int J Cardiol. 2015 Jan 20; 179: 90-4.
38.
Wiebe J, Rixe J, Nef H. Percutaneous closure of a hemodynamically significant connection
between the inferior vena cava and the left atrium. Catheter Cardiovasc Interv. 2015 Jan 9: In
press.
2014
(44)
39.
Aslam M, Tanislav C, Troidl C, Schulz R, Hamm C, Gündüz D. cAMP controls the restoration of
endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation.
Physiol Rep. 2014 Oct 1; 2(10): e12175.
40.
Bauer P, Koshty A, Hamm CW, Gündüz D. Ultrasound guided percutaneous thrombin injection
in a radial artery pseudoaneurysm following percutaneous coronary intervention. Clin Res
Cardiol. 2014 Jul 22; 103(12): 1022-4.
41.
Bauer T. [When to stop dual antiplatelet treatment after PCI?--Cessation of dual antiplatelet
treatment only under specific conditions]. Dtsch Med Wochenschr. 2014 Jan; 139(4): 126.
42.
Bauer T, Hamm C. Akutes Koronarsyndrom und antithrombozytäre Therapie - Prähospitale
Phase: nichts, ASS oder...? Herz. 2014 39(7): 803-807.
43.
Bauer T, Linke A, Sievert H, Kahlert P, Hambrecht R, Nickenig G, Hauptmann KE, Sack S,
Gerckens U, Schneider S, Zeymer U, Zahn R. Comparison of the effectiveness of transcatheter
aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from
the German TAVI Registry). Am J Cardiol. 2014 Feb 1; 113(3): 518-21.
44.
Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, Richardson G, von
Zglinicki T, Saretzki G, Spyridopoulos I. Atorvastatin induces T cell proliferation by a telomerase
reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014 Oct; 236(2): 312-20.
45.
Daniel JM, Penzkofer D, Teske R, Dutzmann J, Koch A, Bielenberg W, Bonauer A, Boon RA,
Fischer A, Bauersachs J, van Rooij E, Dimmeler S, Sedding DG. Inhibition of miR-92a improves
re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc
Res. 2014 Sep 1; 103(4): 564-72.
46.
Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Rixe J, Hamm C, Nef H. Soluble fms-Like
Tyrosine Kinase-1 and Endothelial Adhesion Molecules (Intercellular Cell Adhesion Molecule-1
and Vascular Cell Adhesion Molecule-1) as Predictive Markers for Blood Pressure Reduction
After Renal Sympathetic Denervation. Hypertension. 2014 Jan 27; 63(5): 984-90.
47.
Feustel A, Hahn A, Schneider C, Sieweke N, Franzen W, Gündüz D, Rolfs A, Tanislav C.
Continuous cardiac troponin I release in Fabry disease. PLoS One. 2014 9(3): e91757.
48.
Fischer-Rasokat U, Honold J, Lochmann D, Liebetrau C, Leick J, Hamm C, Fichtlscherer S,
Möllmann H, Spyridopoulos I. Ivabradine therapy to unmask heart rate-independent effects of
beta-blockers on pulse wave reflections. Clin Res Cardiol. 2014 Jun; 103(6): 487-94.
49.
Hamm CW, Liebetrau C. Revaskularisationsoptionen bei stabiler KHK – pro PCI. Aktuel
Kardiol. 2014 //05.11.2014; 3(05): 301-304.
50.
Hamm CW, Möllmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH,
Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK,
Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW. The German Aortic
Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014 Jun 21; 35(24): 1588-98.
51.
Hoffmann J, Ospelt M, Troidl C, Voss S, Liebetrau C, Kim WK, Rolf A, Wietelmann A, Braun
T, Troidl K, Sadayappan S, Barefield D, Hamm C, Nef H, Möllmann H. Sham Surgery and InterIndividual Heterogeneity Are Major Determinants of Monocyte Subset Kinetics in a Mouse
Model of Myocardial Infarction. PLoS One. 2014 9(6): e98456.
52.
Hoffmann J, Spyridopoulos I. Senescent cytotoxic T cells in acute myocardial infarction:
innocent bystanders or the horsemen of apocalypse? Cell Mol Immunol. 2014 Sep 22: In press.
53.
Kastaun S, Gerriets T, Yeniguen M, Nef H, Moellmann H, Sammer G, Juenemann M. Locus of
control and stress management strategies in women with takotsubo cardiomyopathy. Int J Cardiol.
2014 Dec 15; 177(2): 658-60.
54.
Kastaun S, Schwarz NP, Juenemann M, Yeniguen M, Nef HM, Moellmann H, Hamm CW,
Sammer G, Hennig J, Bachmann G, Gerriets T. Cortisol awakening and stress response,
personality and psychiatric profiles in patients with takotsubo cardiomyopathy. Heart. 2014 Nov
15; 100(22): 1786-92.
55.
Kempfert J, Meyer A, Kim WK, van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther
T. First experience without pre-ballooning in transapical aortic valve implantation: a propensity
score-matched analysis. Eur J Cardiothorac Surg. 2014 Mar 27: In press.
56.
Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, Bachmann G, Nef H,
Hamm C, Walther T, Möllmann H. Detection of Myocardial Injury by CMR After Transcatheter
Aortic Valve Replacement. J Am Coll Cardiol. 2014 Jul 29; 64(4): 349-57.
57.
Kuster DW, Cardenas-Ospina A, Miller L, Liebetrau C, Troidl C, Nef HM, Möllmann H, Hamm
CW, Pieper KS, Mahaffey KW, Kleiman NS, Stuyvers BD, Marian AJ, Sadayappan S. Release
kinetics of circulating cardiac myosin binding protein-C following cardiac injury. Am J Physiol
Heart Circ Physiol. 2014 Feb; 306(4): H547-56.
58.
Lauten A, Figulla HR, Möllmann H, Holzhey D, Kötting J, Beckmann A, Veit C, Cremer J, Kuck
KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G,
Meinertz T, Neumann T, Welz A, Mohr FW, Hamm CW. TAVI for low-flow, low-gradient
severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the
German Aortic Valve Registry (GARY). EuroIntervention. 2014 Nov 20; 10(7): 850-9.
59.
Ledwoch J, Franke J, Baldus S, Schillinger W, Bekeredjian R, Boekstegers P, Hink U, Kuck KH,
Ouarrak T, Möllmann H, Nickenig G, Senges J, Franzen O, Sievert H. Impact of the learning
curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve
Registry. Clin Res Cardiol. 2014 Jun 13; 103(11): 930-7.
60.
Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A,
Möllmann H, Hamm C, Nef H. Neutrophil gelatinase-associated lipocalin (NGAL) for the early
detection of contrast-induced nephropathy after percutaneous coronary intervention. Scand J Clin
Lab Invest. 2014 Dec 5; 74(2): 81-8.
61.
Liebetrau C, Gaede L, Dörr O, Hoffmann J, Wolter JS, Weber M, Rolf A, Hamm CW, Nef HM,
Möllmann H. High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic
accuracy of exercise stress test in patients with suspected coronary artery disease. Eur J Prev
Cardiol. 2014 Apr 3: In press.
62.
Liebetrau C, Gaede L, Dörr O, Troidl C, Voss S, Hoffmann J, Paszko A, Weber M, Rolf A,
Hamm C, Nef H, Möllmann H. Release kinetics of N-terminal pro-B-type natriuretic peptide in a
clinical model of acute myocardial infarction. Clin Chim Acta. 2014 Feb 15; 429: 34-7.
63.
Liebetrau C, Möllmann H, Troidl C, Nef H. Reply: Effects of Heparin on Temporal MicroRNA
Profiles. J Am Coll Cardiol. 2014 Nov 25; 63(9): 941-942.
64.
Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J, Hahnel A, Rolf A, Troidl C, Lackner KJ,
Keller T, Hamm CW, Möllmann H. Release kinetics of early ischaemic biomarkers in a clinical
model of acute myocardial infarction. Heart. 2014 Apr; 100(8): 652-7.
65.
Liebetrau C, Nef HM, Hamm CW. Troponin: more lessons to learn. Eur Heart J. 2014 Sep 10;
35(6): 338-40.
66.
Meredith IT, Teirstein PS, Bouchard A, Carrie D, Möllmann H, Oldroyd KG, Hall J, Allocco DJ,
Dawkins KD, Stone GW. Three-year results comparing platinum-chromium PROMUS element
and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing
(from the PLATINUM Trial). Am J Cardiol. 2014 Apr 1; 113(7): 1117-23.
67.
Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C,
Müller C, Müller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E. Early
discharge using single cardiac troponin and copeptin testing in patients with suspected acute
coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2014
Apr 30: In press.
68.
Mohr FW, Holzhey D, Möllmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH,
Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK,
Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW. The German Aortic
Valve Registry: 1-year results from 13 680 patients with aortic valve disease. Eur J Cardiothorac
Surg. 2014 Nov; 46(5): 808-16.
69.
Möllmann H, Kim WK, Kempfert J, Blumenstein J, Liebetrau C, Nef H, Van Linden A, Walther
T, Hamm C. Transfemoral Aortic Valve Implantation of Edwards SAPIEN XT Without
Predilatation Is Feasible. Clin Cardiol. 2014 Jul 31; 37(11): 667-71.
70.
Nef H, Möllmann H, Elsässer A, Hamm C. Sind neue diagnostische Verfahren hilfreich?
CardioVasc. 2014 2014/06/01; 14(3): 48-50.
71.
Rackauskas G, Saygili E, Rana OR, Saygili E, Gemein C, Laucevicius A, Aidietis A, Marinskis
G, Serpytis P, Plisiene J, Pauza DH, Schauerte P. Sub-threshold high frequency electrical field
stimulation induces VEGF expression in cardiomyocytes. Cell Transplant. 2014 Jul 8: In press.
72.
Renker M, Schoepf UJ, Wang R, Meinel FG, Rier JD, Bayer RR, 2nd, Möllmann H, Hamm CW,
Steinberg DH, Baumann S. Comparison of diagnostic value of a novel noninvasive coronary
computed tomography angiography method versus standard coronary angiography for assessing
fractional flow reserve. Am J Cardiol. 2014 Nov 1; 114(9): 1303-8.
73.
Rohrbach S, Aslam M, Niemann B, Schulz R. Impact of caloric restriction on myocardial
ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Br J Pharmacol.
2014 Jun; 171(12): 2964-92.
74.
Rolf A, Rixe J, Kim WK, Borgel J, Möllmann H, Nef HM, Liebetrau C, Kramm T, Guth S,
Krombach GA, Mayer E, Hamm CW. Right ventricular adaptation to pulmonary pressure load in
patients with chronic thromboembolic pulmonary hypertension before and after successful
pulmonary endarterectomy - a cardiovascular magnetic resonance study. J Cardiovasc Magn
Reson. 2014 16: 96.
75.
Sajjad A, Novoyatleva T, Vergarajauregui S, Troidl C, Schermuly RT, Tucker HO, Engel FB.
Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis. Biochim
Biophys Acta. 2014 Nov; 1843(11): 2556-62.
76.
Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR,
Weissmann N, Grimminger F, Seeger W, Schermuly RT, Pullamsetti SS. Pro-proliferative and
inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat
Med. 2014 Nov; 20(11): 1289-300.
77.
Schuhbaeck A, Achenbach S, Pflederer T, Marwan M, Schmid J, Nef H, Rixe J, Hecker F,
Schneider C, Lell M, Uder M, Arnold M. Reproducibility of aortic annulus measurements by
computed tomography. Eur Radiol. 2014 Aug; 24(8): 1878-88.
78.
Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J,
Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Möllmann
H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N,
Schnabel RB. Development of a risk score for outcome after transcatheter aortic valve
implantation. Clin Res Cardiol. 2014 Aug; 103(8): 631-40.
79.
Van Linden A, Blumenstein J, Möllmann H, Kim WK, Walther T, Kempfert J. Image-based
decision-making treatment of degenerated mitroflow and trifecta prostheses. Ann Thorac Surg.
2014 Nov; 98(5): 1809-13.
80.
Van Linden A, Kempfert J, Blumenstein J, Möllmann H, Kim WK, Alkaya S, Hamm C, Walther
T. Manual versus automatic detection of aortic annulus plane in a computed tomography scan for
transcatheter aortic valve implantation screening. Eur J Cardiothorac Surg. 2014 Aug; 46(2): 20712.
81.
Wiebe J, Möllmann H, Most A, Dörr O, Weipert K, Rixe J, Liebetrau C, Elsässer A, Achenbach
S, Hamm C, Nef H. Short-term outcome of patients with ST-segment elevation myocardial
infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold. Clin Res
Cardiol. 2014 Feb; 103(2): 141-8.
82.
Wiebe J, Nef HM, Hamm CW. Current Status of Bioresorbable Scaffolds in the Treatment of
Coronary Artery Disease. J Am Coll Cardiol. 2014 Dec 16; 64(23): 2541-2551.
2013
(48)
83.
Aslam M, Schlüter KD, Rohrbach S, Rafiq A, Nazli S, Piper HM, Noll T, Schulz R, Gündüz D.
Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light
chain kinase. J Physiol. 2013 Jan 15; 591(Pt 2): 461-73.
84.
Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D. Nucleoside
triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: Role of P2Y1
and P2Y12 receptors. Thromb Res. 2013 Nov; 132(5): 548-57.
85.
Bauer T, Gitt AK, Hochadel M, Möllmann H, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J,
Zeymer U. Left circumflex artery-related myocardial infarction: Does ST elevation matter?
Results from the Euro Heart Survey PCI registry. Int J Cardiol. 2013 Oct 15; 168(6): 5239-42.
86.
Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW,
Marco J, Gitt AK. Prima-vista multi-vessel percutaneous coronary intervention in
haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients
in the EHS-PCI registry. Int J Cardiol. 2013 Jul 1; 166(3): 596-600.
87.
Blumenstein J, Kempfert J, Kim W, Liebetrau C, Möllmann H, Walther T. Transapical access and
closure devices: rationale and current status. Expert Rev Cardiovasc Ther. 2013 Dec; 11(12):
1613-7.
88.
Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Möllmann H, Kim WK, Walther T.
Sutureless transapical access and closure to facilitate transapical transcatheter aortic valve
implantation: first-in-human use. J Am Coll Cardiol. 2013 Aug 20; 62(8): 763.
89.
Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Schmidt SK, Möllmann H, Kim WK,
Thourani V, Walther T. First-in-man evaluation of the transapical APICA ASC access and
closure device: the initial 10 patients. Eur J Cardiothorac Surg. 2013 Apr 5; 44(6): 1057-1062.
90.
Blumenstein J, Liebetrau C, Van Linden A, Moellmann H, Walther T, Kempfert J. Recent
advances in transcatheter aortic valve implantation: novel devices and potential shortcomings.
Curr Cardiol Rev. 2013 Nov; 9(4): 274-80.
91.
Blumenstein J, Van Linden A, Kim WK, Skwara W, Schoenburg M, Arsalan M, Moellmann H,
Niederhagen M, Kempfert J, Walther T. Early SAPIEN transcatheter heart valve dysfunction due
to tissue ingrowth in an octogenarian. Clin Res Cardiol. 2013 Mar; 102(3): 237-40.
92.
Blumenstein J, Van Linden A, Moellmann H, Walther T, Kempfert J. Transcatheter Heart Valves:
Specific Characteristics and Potential Shortcomings. Curr Cardiol Rev. 2013 Dec 2: In press.
93.
Blumenstein JM, Van Linden A, Moellmann H, Seeburger J, Rastan A, Kim WK, Mohr FW,
Kempfert J, Walther T. DynaCT-guided anatomical rotation of the SAPIEN XT valve during
transapical aortic valve implantation: proof of concept. Thorac Cardiovasc Surg. 2013 Aug;
61(5): 409-13.
94.
Cabrera-Fuentes HA, Aslam M, Saffarzadeh M, Kolpakov A, Zelenikhin P, Preissner KT,
Ilinskaya ON. Internalization of Bacillus intermedius ribonuclease (BINASE) induces human
alveolar adenocarcinoma cell death. Toxicon. 2013 Jul; 69: 219-26.
95.
Dörr O, Hamm C, Nef HM. Single-side renal sympathetic denervation in a hypertensive patient
with a single kidney. Am J Kidney Dis. 2013 Jun; 61(6): 1042-3.
96.
Dörr O, Liebetrau C, Hecker F, Wiebe J, Möllmann H, Hamm C, Nef H. "Full bioresorbable
jacket" : A new era has begun. Herz. 2013 Aug 2; 40(2): 255-256.
97.
Dörr O, Liebetrau C, Möllmann H, Achenbach S, Sedding D, Szardien S, Willmer M, Rixe J,
Troidl C, Elsässer A, Hamm C, Nef HM. Renal sympathetic denervation does not aggravate
functional or structural renal damage. J Am Coll Cardiol. 2013 Jan 29; 61(4): 479-80.
98.
Dörr O, Liebetrau C, Möllmann H, Rixe J, Hecker F, Szardien S, Willmer M, Hamm C, Nef HM.
Influence of renal sympathetic denervation on quality of life. J Interv Cardiol. 2013 Oct; 26(5):
536-41.
99.
Hoffmann R, Möllmann H, Lotfi S. Transcatheter aortic valve-in-valve implantation of a
CoreValve in a degenerated stenotic Sapien heart valve prosthesis. Catheter Cardiovasc Interv.
2013 Dec 1; 82(7): E922-5.
100.
Kasseckert SA, Shahzad T, Miqdad M, Stein M, Abdallah Y, Scharbrodt W, Oertel M. The
mechanisms of energy crisis in human astrocytes after subarachnoid hemorrhage. Neurosurgery.
2013 Mar; 72(3): 468-74; discussion 474.
101.
Leick J, Liebetrau C, Szardien S, Fischer-Rasokat U, Willmer M, van Linden A, Blumenstein J,
Nef H, Rolf A, Arlt M, Walther T, Hamm C, Möllmann H. Door-to-implantation time of
extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac
arrest. Clin Res Cardiol. 2013 Sep; 102(9): 661-9.
102.
Leick J, Szardien S, Liebetrau C, Willmer M, Fischer-Rasokat U, Kempfert J, Nef H, Rolf A,
Walther T, Hamm C, Möllmann H. Mobile left ventricular thrombus in left ventricular
dysfunction: case report and review of literature. Clin Res Cardiol. 2013 Jul; 102(7): 479-84.
103.
Liebetrau C, Blumenstein J, Rolf A, Kempfert J, Walther T, Hamm C, Möllmann H. Too late, or
not too late: that is the question. Thorac Cardiovasc Surg. 2013 Dec; 61(8): 694-5.
104.
Liebetrau C, Dörr O, Baumgarten H, Gaede L, Szardien S, Blumenstein J, Rolf A, Möllmann H,
Hamm C, Walther T, Nef H, Weber M. Neutrophil gelatinase-associated lipocalin (NGAL) for
the early detection of cardiac surgery associated acute kidney injury. Scand J Clin Lab Invest.
2013 Aug; 73(5): 392-9.
105.
Liebetrau C, Möllmann H, Dörr O, Szardien S, Troidl C, Willmer M, Voss S, Gaede L, Rixe J,
Rolf A, Hamm C, Nef H. Release kinetics of circulating muscle-enriched microRNAs in patients
undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol. 2013 Sep 10;
62(11): 992-8.
106.
Liebetrau C, Nef H, Dörr O, Möllmann H. Validität von Biomarkern zur Abschätzung des
perioperativen Myokardischämierisikos. Gefässchirurgie. 2013 2013(4): 253-260.
107.
Liebetrau C, Nef H, Szardien S, Dörr O, Willmer M, Voss S, Troidl C, Hoffmann J, Rixe J, Rolf
A, Hamm C, Möllmann H. Release kinetics of copeptin in patients undergoing transcoronary
ablation of septal hypertrophy. Clin Chem. 2013 Mar; 59(3): 566-9.
108.
Liosis S, Bauer T, Schiele R, Gohlke H, Gottwik M, Katus H, Sabin G, Zahn R, Schneider S,
Rauch B, Senges J, Zeymer U. Predictors of 1-year mortality in patients with contemporary
guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.
Clin Res Cardiol. 2013 Sep; 102(9): 671-7.
109.
Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACURATE TF
aortic bioprosthesis. EuroIntervention. 2013 Sep 10; 9 Suppl: S107-10.
110.
Möllmann H, Kim WK, Walther T, Hamm C. Transkatheteraortenklappenersatz (TAVI). Internist
(Berl). 2013 54(12): 1469-1483.
111.
Möllmann H, Liebetrau C, Nef H, Kempfert J, Walther T, Hamm C. [Transcutaneous aortic valve
implantation]. Internist (Berl). 2013 Jan; 54(1): 28-34, 36-38.
112.
Möllmann H, Szardien S, Kempfert J, Nef H, Liebetrau C, Walther T, Hamm C. [Myocardial
revascularization]. Herz. 2013 Aug; 38(5): 513-26; quiz 527-8.
113.
Parahuleva MS, Ball N, Parviz B, Zandt D, Abdallah Y, Tillmanns H, Hoelschermann H, Kanse
SM. Factor seven activating protease (FSAP) expression in human placenta and its role in
trophoblast migration. Eur J Obstet Gynecol Reprod Biol. 2013 Mar; 167(1): 34-40.
114.
Rolf A, Werner GS, Schuhbäck A, Rixe J, Möllmann H, Nef HM, Gundermann C, Liebetrau C,
Krombach GA, Hamm CW, Achenbach S. Preprocedural coronary CT angiography significantly
improves success rates of PCI for chronic total occlusion. Int J Cardiovasc Imaging. 2013 Jun 23;
29(8): 1819-1827.
115.
Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, Modine T,
Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A,
Medvedofsky D, Patterson T, Woitek F, Jahangiri M, Laborde JC, Brecker SJ. Transcatheter
aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol.
2013 Apr 16; 61(15): 1577-84.
116.
Sedding DG, Widmer-Teske R, Mueller A, Stieger P, Daniel JM, Gündüz D, Pullamsetti S, Nef
H, Moellmann H, Troidl C, Hamm C, Braun-Dullaeus R. Role of the phosphatase PTEN in early
vascular remodeling. PLoS One. 2013 8(3): e55445.
117.
Shahzad T, Kasseckert SA, Iraqi W, Johnson V, Schulz R, Schlüter KD, Dörr O, Parahuleva M,
Hamm C, Ladilov Y, Abdallah Y. Mechanisms involved in postconditioning protection of
cardiomyocytes against acute reperfusion injury. J Mol Cell Cardiol. 2013 58(May): 209-16.
118.
Shao Y, Redfors B, Scharin Tang M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Boren
J, Omerovic E. Novel rat model reveals important roles of beta-adrenoreceptors in stress-induced
cardiomyopathy. Int J Cardiol. 2013 Oct 3; 168(3): 1943-50.
119.
Shao Y, Redfors B, Stahlman M, Tang MS, Miljanovic A, Möllmann H, Troidl C, Szardien S,
Hamm C, Nef H, Boren J, Omerovic E. A mouse model reveals an important role for
catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J
Heart Fail. 2013 Jan; 15(1): 9-22.
120.
Steg PG, van 't Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van
Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L,
Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M,
Goldstein P. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013
Dec 5; 369(23): 2207-17.
121.
Streitner F, Hamm K, Wittstein IS, Baranchuk A, Akashi YJ, Nef HM, Bonello L, Wolpert C,
Borggrefe M, Haghi D. Is abnormal myocardial repolarization associated with the occurrence of
malignant tachyarrhythmias in Takotsubo cardiomyopathy? Cardiol J. 2013 20(6): 633-8.
122.
Szardien S, Möllmann H, Willmer M, Akashi YJ, Hamm CW, Nef HM. Mechanisms of stress
(takotsubo) cardiomyopathy. Heart Fail Clin. 2013 Apr; 9(2): 197-205.
123.
Szardien S, Möllmann H, Willmer M, Liebetrau C, Voss S, Troidl C, Hoffmann J, Rixe J,
Elsässer A, Hamm CW, Nef HM. Molecular basis of disturbed extracellular matrix homeostasis
in stress cardiomyopathy. Int J Cardiol. 2013 Sep 30; 168(2): 1685-8.
124.
Troidl C, Jung G, Troidl K, Hoffmann J, Möllmann H, Nef H, Schaper W, Hamm CW, SchmitzRixen T. The temporal and spatial distribution of macrophage subpopulations during
arteriogenesis. Curr Vasc Pharmacol. 2013 Jan; 11(1): 5-12.
125.
Van Linden A, Blumenstein J, Walther T, Möllmann H, Kim WK, Hamm C, Kempfert J. Rescue
valve-in-valve implantations in second generation transapical transcatheter aortic valve
prostheses. Clin Res Cardiol. 2013 Mar; 102(3): 241-3.
126.
Weber M, Luchner A, Seeberger M, Mueller C, Liebetrau C, Schlitt A, Apostolovic S, Jankovic
R, Bankovic D, Jovic M, Mitrovic V, Nef H, Möllmann H, Hamm CW. Incremental value of
high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk
stratification in non-cardiac surgery. Eur Heart J. 2013 Mar; 34(11): 853-62.
127.
Werner N, Bauer T, Hochadel M, Zahn R, Weidinger F, Marco J, Hamm C, Gitt AK, Zeymer U.
Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results
of the Euro heart survey percutaneous coronary interventions registry. Circ Cardiovasc Interv.
2013 Aug; 6(4): 362-9.
128.
Zahn R, Bauer T, Sack FU, Lehman A, Cornelius B, Schiele R. A plea for caution: transcatheter
aortic valve implantation using the Medtronic CoreValve prosthesis without balloon predilatation.
EuroIntervention. 2013 Sep; 9(5): 654.
129.
Zahn R, Erbel R, Nienaber CA, Neumann FJ, Nef H, Eggebrecht H, Senges J. Endovascular
aortic repair of thoracic aortic disease: early and 1-year results from a German multicenter
registry. J Endovasc Ther. 2013 Jun; 20(3): 265-72.
130.
Zahn R, Schiele R, Zeymer U, Bauer T, Lehmann A, Cornelius B, Sack FU. Occlusion of the left
main stem: a rare, but life-threatening complication of transcatheter aortic valve implantation
with the Medtronic CoreValve prosthesis. Clin Res Cardiol. 2013 Apr; 102(4): 323-6.
2012
(26)
131.
Appukuttan A, Kasseckert SA, Micoogullari M, Flacke JP, Kumar S, Woste A, Abdallah Y, Pott
L, Reusch HP, Ladilov Y. Type 10 adenylyl cyclase mediates mitochondrial Bax translocation
and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion. Cardiovasc
Res. 2012 Feb 1; 93(2): 340-9.
132.
Aslam M, Pfeil U, Gündüz D, Rafiq A, Kummer W, Piper HM, Noll T. Intermedin
(adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier
failure in endothelial cell monolayers. Br J Pharmacol. 2012 Jan; 165(1): 208-22.
133.
Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Konorza T,
Möllmann H, Hehrlein C, Ouarrak T, Senges J, Meinertz T. MitraClip therapy in daily clinical
practice: initial results from the German transcatheter mitral valve interventions (TRAMI)
registry. Eur J Heart Fail. 2012 Sep; 14(9): 1050-5.
134.
Basic D, Möllmann H, Haas MA, Rolf A, Jovanovic A, Liebetrau C, Szardien S, Leick J, Dörr O,
Skwara A, Walther T, Hamm CW, Nef HM. A TASH experience: post-infarction myocardial
oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation.
Clin Res Cardiol. 2012 Feb; 101(2): 149-53.
135.
Bauer T, Möllmann H, Zeymer U, Hochadel M, Nef H, Weidinger F, Zahn R, Hamm CW, Marco
J, Gitt AK. Multivessel percutaneous coronary intervention in patients with stable angina: a
common approach? Lessons learned from the EHS PCI registry. Heart Vessels. 2012 Sep; 27(5):
453-9.
136.
Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW,
Marco J, Gitt AK. Use and outcomes of multivessel percutaneous coronary intervention in
patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI
Registry). Am J Cardiol. 2012 Apr 1; 109(7): 941-6.
137.
Blumenstein J, Van Linden A, Arsalan M, Moellmann H, Liebetrau C, Walther T, Kempfert J.
Transapical access: current status and future directions. Expert Rev Med Devices. 2012 Jan; 9(1):
15-22.
138.
Blumenstein J, Van Linden A, Arsalan M, Voss S, Moellmann H, Liebetrau C, Thourani VH,
Walther T, Kempfert J. Experimental evaluation of a new apical access and closure device. Ann
Thorac Surg. 2012 Nov; 94(5): 1706-9.
139.
Blumenstein J, Van Linden A, Kempfert J, Kim WK, Liebetrau C, Hamm C, Nef H, Walther T,
Moellmann H. Retrograde, transsubclavian implantation of a SAPIEN XT aortic valve prosthesis
with the Edwards NovaFlex+ system. Clin Res Cardiol. 2012 Sep; 101(9): 773-5.
140.
Damman P, Abdel-Wahab M, Möllmann H, Richardt G, Chevalier B, Barragan P, Tijssen JG,
Underwood P, Hamm CW. Comparison of twelve-month outcomes after percutanous coronary
intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from
the PROENCY (PROmus ENdeavor CYpher) registry. J Invasive Cardiol. 2012 Oct; 24(10): 495502.
141.
Daniel JM, Dutzmann J, Bielenberg W, Widmer-Teske R, Gündüz D, Hamm CW, Sedding DG.
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima
formation. Basic Res Cardiol. 2012 107(3): 261.
142.
Dörr O, Möllmann H, Achenbach S, Sedding D, Basic D, Liebetrau C, Szardien S, Elsässer A,
Roth P, Böning A, Hamm C, Nef HM. Transapical coronary artery intervention: "first-in-man"
experience. Circ Cardiovasc Interv. 2012 Jun; 5(3): 446-7.
143.
Gündüz D, Aslam M, Krieger U, Becker L, Grebe M, Arshad M, Sedding DG, Härtel FV,
Abdallah Y, Piper HM, Voss RK, Noll T. Opposing effects of ATP and adenosine on barrier
function of rat coronary microvasculature. J Mol Cell Cardiol. 2012 May; 52(5): 962-70.
144.
Kempfert J, Möllmann H, Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012 Sep;
8 Suppl Q: Q102-9.
145.
Leick J, Liebetrau C, Szardien S, Willmer M, Rixe J, Nef H, Rolf A, Hamm C, Möllmann H.
Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary
embolism. Clin Res Cardiol. 2012 Dec; 101(12): 1017-20.
146.
Leick J, Möllmann H, Hamm C. Prästationäre Diagnostik und Therapie des Akuten
Koronarsyndroms-Kooperationen und Netzwerke zur gezielten Therapieeinleitung. Der
Klinikarzt. 2012 41(11): 514-521.
147.
Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, Willmer M, Hoffmann J, Weber
M, Rolf A, Hamm C. Release kinetics of cardiac biomarkers in patients undergoing transcoronary
ablation of septal hypertrophy. Clin Chem. 2012 Jun; 58(6): 1049-54.
148.
Maxeiner H, Abdallah Y, Kuhlmann CR, Schlüter KD, Wenzel S. Effects of cerivastatin on
adrenergic pathways, hypertrophic growth and TGFbeta expression in adult ventricular
cardiomyocytes. Eur J Cell Biol. 2012 May; 91(5): 367-74.
149.
Möllmann H, Szardien S, Kempfert J, Nef H, Liebetrau C, Walther T, Hamm C. [Myocardial
revascularization]. Internist (Berl). 2012 Sep; 53(9): 1063-75; quiz 1076-8.
150.
Nef HM, Dörr O, Hamm C. Interventionelle Strategie beim NSTE-ACS-Diagnostik,
Risikoabschätzung und optimale Intervention. Der Klinikarzt. 2012 41(11): 542-545.
151.
Parahuleva MS, Langanke E, Holschermann H, Parviz B, Abdallah Y, Stracke S, Tillmanns H,
Kanse SM. Nicotine modulation of factor VII activating protease (FSAP) expression in human
monocytes. J Atheroscler Thromb. 2012 19(11): 962-9.
152.
Rixe J, Schuhbaeck A, Liebetrau C, Moellmann H, Nef HM, Szardien S, Brandt R, Schmitt J,
Neumann T, Schneider C, Krombach G, Hamm CW, Achenbach S, Rolf A. Multi-detector
computed tomography is equivalent to trans-oesophageal echocardiography for the assessment of
the aortic annulus before transcatheter aortic valve implantation. Eur Radiol. 2012 Dec; 22(12):
2662-9.
153.
Szardien S, Nef HM, Troidl C, Willmer M, Voss S, Liebetrau C, Hoffmann J, Rolf A, Rixe J,
Elsässer A, Hamm CW, Möllmann H. Bone marrow-derived cells contribute to cell turnover in
aging murine hearts. Int J Mol Med. 2012 Aug; 30(2): 283-7.
154.
Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, Rauch M, Mayer K, Kimmich
K, Rolf A, Rixe J, Troidl K, Kojonazarov B, Schermuly RT, Kostin S, Elsässer A, Hamm CW,
Möllmann H. Regression of cardiac hypertrophy by granulocyte colony-stimulating factorstimulated interleukin-1beta synthesis. Eur Heart J. 2012 Mar; 33(5): 595-605.
155.
Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen
K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B,
Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H,
Schneider S, Ebelt H, Werdan K, Zeymer U. Intraaortic balloon counterpulsation in acute
myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic
Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012 Jun; 163(6):
938-45.
156.
Urban D, Härtel FV, Gadiraju K, Gündüz D, Aslam M, Piper HM, Noll T. Extracellular ATP
attenuates ischemia-induced caspase-3 cleavage in human endothelial cells. Biochem Biophys
Res Commun. 2012 Aug 24; 425(2): 230-6.
2011
(21)
157.
Abdallah Y, Kasseckert SA, Iraqi W, Said M, Shahzad T, Erdogan A, Neuhof C, Gündüz D,
Schlüter KD, Tillmanns H, Piper HM, Reusch HP, Ladilov Y. Interplay between Ca2+ cycling
and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac
myocytes. J Cell Mol Med. 2011 Nov; 15(11): 2478-85.
158.
Aslam M, Gündüz D, Schuler D, Li L, Sharifpanah F, Sedding D, Piper HM, Noll T. Intermedin
induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton:
role of RhoA and Rac1. Cardiovasc Res. 2011 Nov 1; 92(2): 276-86.
159.
Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian
A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Impact of diabetes
mellitus status on coronary pathoanatomy and interventional treatment: insights from the Euro
heart survey PCI registry. Catheter Cardiovasc Interv. 2011 Nov 1; 78(5): 702-9.
160.
Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian
A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Predictors of
hospital mortality in the elderly undergoing percutaneous coronary intervention for acute
coronary syndromes and stable angina. Int J Cardiol. 2011 Sep 1; 151(2): 164-9.
161.
Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H,
Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW. Randomized
comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary
artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011 Feb 1;
57(5): 538-45.
162.
Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H,
Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M.
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
JACC Cardiovasc Interv. 2011 Nov; 4(11): 1218-27.
163.
Hamm CW, Nef HM, Rolf A, Möllmann H. Calcium and C-reactive protein hot enough to predict
the future? J Am Coll Cardiol. 2011 Mar 29; 57(13): 1465-7.
164.
Härle T, Kronberg K, Nef H, Möllmann H, Elsässer A. Inverted Takotsubo cardiomyopathy
following accidental intravenous administration of epinephrine in a young woman. Clin Res
Cardiol. 2011 May; 100(5): 471-3.
165.
Heger J, Warga B, Meyering B, Abdallah Y, Schlüter KD, Piper HM, Euler G. TGFbeta receptor
activation enhances cardiac apoptosis via SMAD activation and concomitant NO release. J Cell
Physiol. 2011 Oct; 226(10): 2683-90.
166.
Liebetrau C, Szardien S, Rixe J, Woelken M, Rolf A, Bauer T, Nef H, Möllmann H, Hamm C,
Weber M. Direct admission versus transfer of AMI patients for primary PCI. Clin Res Cardiol.
2011 Mar; 100(3): 217-25.
167.
Meissner J, Nef H, Darga J, Kovacs M, Weber M, Hamm C, Möllmann H, Twerenbold R, Reiter
M, Heinisch C, Stelzig C, Reichlin T, Mueller C. Endogenous stress response in Tako-Tsubo
cardiomyopathy and acute myocardial infarction. Eur J Clin Invest. 2011 Sep; 41(9): 964-70.
168.
Mengden T, Nef H, Liebetrau C, Dörr O, Möllmann H, Hamm C. Neue Entwicklungen in der
medikamentösen und interventionellen Hochdrucktherapie. Hessisches Ärzteblatt. 2011 72(11):
677-688.
169.
Möllmann H, Liebetrau C, Nef HM, Hamm CW. The Swedish paradox: or is there really no
gender difference in acute coronary syndromes? Eur Heart J. 2011 Dec; 32(24): 3070-2.
170.
Möllmann H, Nef HM, Voss S, Troidl C, Willmer M, Szardien S, Rolf A, Klement M,
Voswinckel R, Kostin S, Ghofrani HA, Hamm CW, Elsässer A. Stem cell-mediated natural tissue
engineering. J Cell Mol Med. 2011 Jan; 15(1): 52-62.
171.
Möllmann H, Szardien S, Liebetrau C, Elsässer A, Rixe J, Rolf A, Nef H, Weber M, Hamm C.
Clinical outcome of patients treated with an early invasive strategy after out-of-hospital cardiac
arrest. J Int Med Res. 2011 39(6): 2169-77.
172.
Munzel G, Schlier A, Schreckenberg R, Abdallah Y, Schlüter KD. Rat intermedin1-47 does not
improve functional recovery in postischemic hearts. Naunyn Schmiedebergs Arch Pharmacol.
2011 Dec; 384(6): 535-42.
173.
Rolf A, Assmus B, Schachinger V, Rixe J, Möllmann S, Möllmann H, Dimmeler S, Zeiher AM,
Hamm CW, Dill T. Maladaptive hypertrophy after acute myocardial infarction positive effect of
bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI. Clin
Res Cardiol. 2011 Nov; 100(11): 983-92.
174.
Schwarz N, Schoenburg M, Möllmann H, Kastaun S, Kaps M, Bachmann G, Sammer G, Hamm
C, Walther T, Gerriets T. Cognitive decline and ischemic microlesions after coronary
catheterization. A comparison to coronary artery bypass grafting. Am Heart J. 2011 Oct; 162(4):
756-63.
175.
Szardien S, Möllmann H, Voss S, Troidl C, Rolf A, Liebetrau C, Rixe J, Elsässer A, Hamm CW,
Nef HM. Elevated serum levels of neuropeptide Y in stress cardiomyopathy. Int J Cardiol. 2011
Feb 17; 147(1): 155-7.
176.
Walther T, Möllmann H, van Linden A, Kempfert J. Transcatheter aortic valve implantation
transapical: step by step. Semin Thorac Cardiovasc Surg. 2011 Spring; 23(1): 55-61.
177.
Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C,
Woelken M, Moellmann H, Nef H, Hamm C. Improved diagnostic and prognostic performance of
a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J.
2011 Jul; 162(1): 81-8.
Related documents